Regulacje i polityka gospodarcza · 30/12/2005

National Institutes of Health to Grant Exclusive License for Molecular Property Prediction and Pathogen Detection Software to Litmus, LLC

The National Institutes of Health is considering granting an exclusive worldwide license to Litmus, LLC to develop and use software for predicting molecular properties and detecting pathogens, as outlined in three U.S. patent applications filed between 2001 and 2004.